Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.79 |
| ▸ | NPC1 | O15118 | 7/20 | 0.79 |
| ▸ | HPGD | P15428 | 2/20 | 0.79 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.79 |
| ▸ | ESR1 | P03372 | 1/20 | 0.69 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.64 |
| ▸ | RELA | Q04206 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29043248 | 0.98 | RAB9A (0.77) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL22319774 | 0.89 | RAB9A (0.71) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL16398364 | 0.89 | RAB9A (1.00) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL11273679 | 0.89 | RAB9A (1.00) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL27832225 | 0.89 | RAB9A (0.71) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL16398834 | 0.89 | RAB9A (0.71) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL5454957 | 0.88 | RAB9A (0.69) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL11686421 | 0.86 | RAB9A (0.67) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL6777691 | 0.86 | RAB9A (0.71) | RAB9ANPC1HPGDL3MBTL1ESR1 | |
| SCHEMBL11759747 | 0.86 | ESR2 (0.77) | RAB9ANPC1HPGDL3MBTL1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105676543-B | Method for manufacturing liquid crystal display device | 乐金显示有限公司 | 2021-02-02 | — | — | CN | claimed |
| US-9834570-B2 | One step process for regioselective synthesis of α-acyloxy carbonyls | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-12-05 | — | — | US | claimed |
| US-20160115182-A1 | ONE STEP PROCESS FOR REGIOSELECTIVE SYNTHESIS OF ALPHA-ACYLOXY CARBONYLS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-04-28 | — | — | US | claimed |
| WO-2014195972-A1 | ONE STEP PROCESS FOR REGIOSELECTIVE SYNTHESIS OF α-ACYLOXY CARBONYLS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2014-12-11 | — | — | WO | claimed |
| EP-0445628-B1 | Polymerizable nematic monomer compositions | HERCULES INC (US) | 1995-01-25 | — | — | EP | claimed |
| EP-0445629-B1 | Process of preparing liquid crystal compositions containing multiple oriented mesogens | HERCULES INC (US) | 1994-09-21 | — | — | EP | claimed |
| US-5202053-A | Blends | HERCULES INCORPORATED (US) | 1993-04-13 | — | — | US | claimed |
| US-5073294-A | Liquid crystal polymers | HERCULES INCORPORATED (US) | 1991-12-17 | — | — | US | claimed |
| EP-0445629-A2 | Process of preparing liquid crystal compositions containing multiple oriented mesogens | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | claimed |
| EP-0445628-A2 | Polymerizable nematic monomer compositions | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | claimed |
| US-20260022036-A1 | PERVAPORATION MEMBRANE | NITTO DENKO CORP (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4596090-A1 | PERVAPORATION MEMBRANE | NITTO DENKO CORPORATION (JP) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024071840-A1 | INFRARED RAY-TRANSMITTING PHOTOSENSITIVE RESIN COMPOSITION | 동우 화인켐 주식회사 | 2024-04-04 | — | — | WO | disclosed |
| CN-109803960-B | Compound, photosensitive resin composition containing the same and color filter | 三星SDI株式会社 | 2023-04-11 | — | — | CN | disclosed |
| CN-109715599-B | Novel compound, core-shell dye, photosensitive resin composition containing the same, and color filter | 三星SDI株式会社 | 2023-02-28 | — | — | CN | disclosed |
| US-5202053-A | Blends | HERCULES INCORPORATED (US) | 1993-04-13 | — | — | US | disclosed |
| US-5073294-A | Liquid crystal polymers | HERCULES INCORPORATED (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0445629-A2 | Process of preparing liquid crystal compositions containing multiple oriented mesogens | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | disclosed |
| EP-0445628-A2 | Polymerizable nematic monomer compositions | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | disclosed |
| US-4637896-A | CHOLESTERIC, PHOTOPOLYMERIZATION, PHOTOINITIATORS, (METH) ACRYLATE DERIVATIVES OF (DIHYDRO)CHOLESTEROL | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1987-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022036-A1 | PERVAPORATION MEMBRANE | SLC2A4, VDAC1, VMA21 | RAB9A 3883/4885NPC1 279/4885HPGD 2783/4885 |
| US-20160115182-A1 | ONE STEP PROCESS FOR REGIOSELECTIVE SYNTHESIS OF ALPHA-ACYLOXY CARBONYLS | ACACB, ACACA, COASY | RAB9A 2287/4885NPC1 327/4885HPGD 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.